(Toxicon[TA])
10,599 results
  • Proteomic and Functional Comparison of Active-Season and Overwintering-Stage Venoms from Naja atra. [Journal Article]
    Toxicon. 2026 Oct 28; :109342. [Online ahead of print]Hu J, Lu X, Guo HT
  • Seasonal changes in physiological state and metabolism may influence snake venom composition and biological activity, yet these relationships remain poorly understood. This study investigated seasonal variation in venom composition and functional properties in Naja atra. Venom samples were collected from the same ten adult snakes during the active season and after approximately two months of over…
  • Protective Effect of Lycopene on Patulin-Induced Liver Injury in Mice. [Journal Article]
    Toxicon. 2026 Oct 26; :109338. [Online ahead of print]Zhang B, Li Q, … Su YT
  • Patulin (PAT) is a mycotoxin that contaminates apples and apple products and is a recognised hepatotoxicant, but practical dietary countermeasures remain undefined. We asked whether lycopene (LYC), a carotenoid antioxidant, limits PAT-induced liver injury in mice. Male Kunming (KM) mice (n = 8 per group) received PAT at 15 μmol kg[-1] body weight (BW) per day (2.31 mg kg[-1] BW per day), LYC at 5…
  • Evidence of venom variability associated with venom extraction interval in the monocled cobra (Najakaouthia). [Journal Article]
    Toxicon. 2026 Oct 22; 285:109336. [Online ahead of print]Vasaruchapong T, Tawan T, … Chaiyabutr NT
  • Snake venom variability is a critical factor in antivenom production. Although several influencing factors have been studied, the impact of extraction interval on venom properties remains poorly understood. This study evaluated the effects of various extraction intervals on venom yield, the percentage of dry weight (%Dw), and composition in the monocled cobra (Naja kaouthia). Twenty-five captive …
  • Mycotoxin-induced DNA damage response and its association with carcinogenesis. [Review]
    Toxicon. 2026 Oct 15; 285:109313. [Online ahead of print]Singh P, Bilachi RS, … Paul MKT
  • Fungal species produce various secondary metabolites with carcinogenic and genotoxic properties, including aflatoxins, ochratoxins, fumonisins, sterigmatocystin, and griseofulvin. Acute or chronic exposure to these mycotoxins through contaminated food and feed can cause DNA damage, chromosomal instability, and epigenetic changes, ultimately leading to cancer. This review focuses on IARC-classifie…
  • Neuroactive mini-M conotoxins in Conus tessulatus. [Journal Article]
    Toxicon. 2026 Oct 14; 285:109322. [Online ahead of print]Mendoza CB, Acyatan ZG, … Salvador-Reyes LAT
  • Two small peptides were purified from the venom of the vermivorous cone snail, Conus tessulatus, and evaluated for neuroactivity. Structural characterization by Edman sequencing and mass spectrometry revealed that the two peptides, named ts3b and ts3c, are 14 amino acids long and can be classified as mini-M conotoxins under framework III, M-superfamily, M2 branch. Native samples of ts3b and ts3c …
  • Two new arthropod toxins purified from the venom of the Mexican scorpion Centruroides nigrescens. [Journal Article]
    Toxicon. 2026 Oct 09; 285:109321. [Online ahead of print]Santamaria-Reyes E, Delgado-Prudencio G, … Possani LDT
  • The venom of the slender black scorpion Centruroides nigrescens, from the State of Guerrero México, was fractionated by Sephadex G-50 gel filtration, followed by carboxymethyl cellulose ion separation and high-performance liquid chromatography, permitting to obtain two new peptides toxic to arthropods. The estimate LD50 of the soluble venom for the insect Acheta domesticus was 11.1 μg/g body weig…
  • Chinese expert consensus on botulinum toxin injection for the treatment of disabling spasticity in adults. [Review]
    Toxicon. 2026 Oct 08; 285:109316. [Online ahead of print]Li F, Jin L, … Han XT
  • CONCLUSIONS: This consensus supports the rational use of BT injection for adult disabling spasticity and provides a decision-making basis for primary care and specialist physicians regarding BT treatment for spasticity caused by different diseases, selection and attainment of treatment goals, common upper- and lower-limb manifestations and injection dose ranges, timing and repetition of BT injection, injection guidance techniques, combined treatment and other treatment options, diagnostic nerve blocks, and cost-effectiveness.